Astrazeneca Plc Adr Stock Price Prediction
| AZN Stock | USD 77.60 1.09 1.42% |
Momentum 73
Buy Stretched
Oversold | Overbought |
Using AstraZeneca PLC hype-based prediction, you can estimate the value of AstraZeneca PLC ADR from the perspective of AstraZeneca PLC response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AstraZeneca PLC to buy its stock at a price that has no basis in reality. In that case, they are not buying AstraZeneca because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AstraZeneca PLC after-hype prediction price | USD 77.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AstraZeneca |
AstraZeneca PLC After-Hype Price Prediction Density Analysis
As far as predicting the price of AstraZeneca PLC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AstraZeneca PLC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AstraZeneca PLC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AstraZeneca PLC Estimiated After-Hype Price Volatility
In the context of predicting AstraZeneca PLC's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AstraZeneca PLC's historical news coverage. AstraZeneca PLC's after-hype downside and upside margins for the prediction period are 76.30 and 78.78, respectively. We have considered AstraZeneca PLC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AstraZeneca PLC is very steady at this time. Analysis and calculation of next after-hype price of AstraZeneca PLC ADR is based on 3 months time horizon.
AstraZeneca PLC Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as AstraZeneca PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AstraZeneca PLC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AstraZeneca PLC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 1.24 | 0.00 | 0.25 | 0 Events / Month | 8 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
77.60 | 77.54 | 0.08 |
|
AstraZeneca PLC Hype Timeline
On the 15th of March 2025 AstraZeneca PLC ADR is traded for 77.60. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.25. AstraZeneca is forecasted to decline in value after the next headline, with the price expected to drop to 77.54. The average volatility of media hype impact on the company price is insignificant. The price depreciation on the next news is expected to be -0.08%, whereas the daily expected return is presently at 0.3%. The volatility of related hype on AstraZeneca PLC is about 146.75%, with the expected price after the next announcement by competition of 77.85. About 17.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.92. AstraZeneca PLC ADR last dividend was issued on the 21st of February 2025. The entity had 2:1 split on the 27th of July 2015. Considering the 90-day investment horizon the next forecasted press release will be in 5 to 10 days. Check out AstraZeneca PLC Basic Forecasting Models to cross-verify your projections.AstraZeneca PLC Related Hype Analysis
Having access to credible news sources related to AstraZeneca PLC's direct competition is more important than ever and may enhance your ability to predict AstraZeneca PLC's future price movements. Getting to know how AstraZeneca PLC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AstraZeneca PLC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NVS | Novartis AG ADR | 0.00 | 0 per month | 1.04 | 0.26 | 2.25 | (2.12) | 7.69 | |
| GSK | GlaxoSmithKline PLC ADR | 0.55 | 8 per month | 1.25 | 0.19 | 3.45 | (2.15) | 11.70 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.94 | 0.32 | 2.63 | (1.92) | 5.52 | |
| BMY | Bristol Myers Squibb | 0.64 | 9 per month | 1.88 | 0.07 | 3.18 | (2.80) | 7.43 | |
| SNY | Sanofi ADR | 0.00 | 0 per month | 0.87 | 0.31 | 2.78 | (1.55) | 10.59 | |
| MRK | Merck Company | 0.39 | 8 per month | 0.00 | (0) | 2.08 | (2.24) | 11.57 | |
| GILD | Gilead Sciences | 1.75 | 9 per month | 0.91 | 0.28 | 2.28 | (2.04) | 9.83 | |
| JNJ | Johnson Johnson | 1.56 | 8 per month | 0.98 | 0.21 | 1.79 | (1.81) | 5.95 | |
| ABBV | AbbVie Inc | 6.67 | 7 per month | 0.69 | 0.30 | 2.37 | (1.47) | 6.46 | |
| LLY | Eli Lilly and | (7.66) | 10 per month | 0.00 | 0.05 | 2.45 | (4.21) | 10.31 | |
| PFE | Pfizer Inc | 0.33 | 8 per month | 1.24 | 0.1 | 2.20 | (2.06) | 7.11 | |
| AMGN | Amgen Inc | 5.91 | 7 per month | 1.24 | 0.22 | 2.22 | (2.59) | 9.76 |
AstraZeneca PLC Additional Predictive Modules
Most predictive techniques to examine AstraZeneca price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AstraZeneca using various technical indicators. When you analyze AstraZeneca charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AstraZeneca PLC Predictive Indicators
The successful prediction of AstraZeneca PLC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AstraZeneca PLC ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AstraZeneca PLC based on analysis of AstraZeneca PLC hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AstraZeneca PLC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AstraZeneca PLC's related companies.
Story Coverage note for AstraZeneca PLC
The number of cover stories for AstraZeneca PLC depends on current market conditions and AstraZeneca PLC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AstraZeneca PLC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AstraZeneca PLC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AstraZeneca PLC Short Properties
AstraZeneca PLC's future price predictability will typically decrease when AstraZeneca PLC's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AstraZeneca PLC ADR often depends not only on the future outlook of the potential AstraZeneca PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AstraZeneca PLC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 B | |
| Cash And Short Term Investments | 5.7 B |
Check out AstraZeneca PLC Basic Forecasting Models to cross-verify your projections. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.